Psyence BiomedicalPBMWWPreferred / convertible
13F holders, Q1 2026 (March 31)19holders −2
1new positions
3sold out
1famous investor
$0.02avg. 13F price*
At the end of Q1 2026, 19 institutions reported holding Psyence Biomedical Ltd. (PBMWW) in their 13F filings, down 2 from Q4 2025. 1 opened new positions and 3 sold out. The largest holders were Harraden Circle Investments, LLC ($21K), Polar Asset Management Partners Inc. ($13K) and MMCAP International Inc. SPC ($11K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4 |
| Exits | 3 | $3K |
All 13F filers, Q4 2025 → Q1 2026: 14,836 shares bought and 223,065 shares sold, net −208,229 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Harraden Circle Investments, LLC | — | No change | 1,150,000 | $21K |
| Polar Asset Management Partners Inc. | — | No change | 733,000 | $13K |
| MMCAP International Inc. SPC | — | No change | 600,000 | $11K |
| Toronto Dominion Bank | — | No change | 503,312 | $9K |
| Calamos Advisors LLC | — | No change | 500,000 | $9K |
| Saba Capital Management, L.P. | — | No change | 297,847 | $5K |
| Clear Street Group Inc. | — | No change | 257,209 | $5K |
| Aristeia Capital, L.L.C. | — | Reduce -13.1% | 215,319 | $4K |
| Goldman Sachs Group Inc. | — | No change | 200,117 | $4K |
| LMR Partners LLP | — | No change | 200,000 | $4K |
| D. E. Shaw & Co. | — | No change | 175,352 | $3K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 150,000 | $3K |
| Wolverine Asset Management LLC | — | No change | 147,101 | $3K |
| Virtu Financial LLC | — | Add +110.0% | 27,853 | $1K |
| Mint Tower Capital Management B.V. | — | No change | 50,000 | $1K |
| LPL Financial LLC | — | No change | 49,095 | $894 |
| Parallel Advisors, LLC | — | No change | 27,500 | $500 |
| Ancora Advisors LLC | — | No change | 5,000 | $90 |
| UBS Group AG | — | New | 247 | $4 |
"% of holder's portfolio" is PBMWW's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.